In association with

 A NEW CLASS 

OF TREATMENT

The FDA has approved the first cannabinoid-based drug in the US, but what does this mean for patients? 

ISSUE 73 I AUGUST 2018

Developing new drugs from soil

The next generation of antimalarials

Air freight certification 

02/23/2024 23:25:31
  • Home | A New Class of Treatment
  • Editorial
  • Pfanstiehl Company Insight
  • Pfanstiehl
  • Contents
  • Daiichi Jitsugyo
  • News
  • Distek
  • The pharma industry briefing
  • DelSiTech
  • Big soil: A $1bn project to develop new drugs from earth
  • Novo Nordisk
  • International Cannabis and Cannabinoid Institute (ICCI) Company Insight
  • International Cannabis and Cannabinoid Institute (ICCI)
  • medical hemp
  • Cannabinoids breakthrough signals hope for epilepsy treatment
  • CBDepot Company Insight
  • CBDepot
  • Capsugel Company Insight
  • Could cutting out mediators let cancer research off the leash?
  • Ecocool
  • The next generation of antimalarials
  • Alpex
  • Pharma air freight: what does it take to get certified?
  • Pangeanic
  • Blocking generic competition: will naming and shaming work?
  • Haselmeier GmbH Company Insight
  • Haselmeier GmbH
  • Events
  • Abiogen Pharma
  • Next issue
  • HOF Sonderanlagenbau
  • Evolve
  • ILC Dover Inc
07/19/2018 00:00:00